Latest Sustainability In It News

ASX Limited reported robust first-half results with 11.2% revenue growth, while advancing a strategic reset in response to the ASIC Inquiry and pushing forward its technology modernization agenda.

Pro Medicus Limited reported a robust half-year performance, with underlying profit after tax rising by approximately 30%, driven by significant new sales and strategic implementations. The company remains confident in its proprietary technology's resilience against AI disruption while expanding its market footprint.

ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.

Pro Medicus Limited has reported a stellar half-year performance with revenue up 28.4% and a surge in net profit, driven by major US contract wins and strategic investments.

Austral Resources is set to unlock significant residual copper at its Mt Kelly site using Hydro-Jex®, a patented heap leach technology promising enhanced recovery without costly reprocessing.

OncoSil Medical’s CEO Nigel Lange has agreed to a 10% salary reduction, opting instead to receive shares at a significant premium, reinforcing executive commitment to shareholder value and cost discipline.

MFF Capital Investments reported a 45% drop in net profit for the half year to December 2025 but declared a higher fully franked dividend, marking a milestone in its operational independence and strategic growth.

Lendlease CEO Tony Lombardo will step down in August 2026, marking a leadership change after five years at the helm and a significant strategic reset. The Board has begun the search for his successor as the company prepares for its next growth phase.

AMP Limited has announced an ordinary dividend of AUD 0.02 per share for the half-year ending December 2025, partially franked at 20%, with payments scheduled for April 2026.

AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.

Entropy Neurodynamics has been granted an Australian patent for its novel two-phase IV infusion method administering psilocybin and psilocin, securing exclusive rights through 2042 and strengthening its lead asset TRP-8803’s competitive position.

Viva Leisure has reported a robust half-year performance with underlying NPAT up 46.8% and revenue climbing to $116.5 million, driven by strong organic membership growth and a booming technology segment.